Newbury Racecourse (NYR) continues to progress its development plans and some of the benefits are shown by the near-doubling of conference and events revenues in the first half. The remodelling of the main parade ring has been completed and a contractor appointed for work on the Royal Box, which will cost £2.5m. In the six months to June 2019, revenues were 3% higher at £7.57m, even though one race day was lost, and there was a slightly lower pre-exceptional loss of £317,000. There is a danger that legislation relating to fixed odds betting terminals could have a knock-on effect on Newbury’s revenues from bookies in the second half.
Shepherd Neame (SHEP) will be releasing its annual results on Wednesday. Peel Hunt expects pre-tax profit to be 5% lower at £11.2m, because there was no contribution from the Asahi brewing contract that ended in 2018. Excluding that contract, profit could have risen. Pubs have grown their like-for-like income and brewing volumes have recovered, but second half profit could be minimal. NAV of 1664p a share is forecast.
Healthcare IT provider DXS International (DXSP) has been hit by a short-term lack of sales activity in the NHS. In the year to April 2019, DXS reported an increased loss of £200,000, up from £46,000. Revenues dipped from £3.41m to £3.35m. More than £1m was spent on developing products during the year.
Ananda Developments (ANA) says that dry herb medical inhalation system Hapac has been refined and sales of the device and Hapac sachets are growing. However, legal uncertainty in Italy means that Hapac has been removed from sale while a court case over labelling and cannabis content is heard in Parma. There are plans to launch Hapac in other markets. Ananda has a 15% stake in Hapac’s owner. Edward Nealon has increased his stake in Ananda from 5.31% to 6.91%.
AfriAg Global (AFRI) says that Apollon Formularies, a Jamaican cannabis company where it owns 2.325% and it intends to acquire the rest of the shares, has completed a six week pilot opening of a medicinal cannabis therapy centre to treat patients.
Karoo Energy (KEP) is in discussions with investors so that the company can be recapitalised and settle outstanding creditors. NEX has agreed to defer the withdrawal of Karoo shares from trading ahead of the publication of a circular.
AFH Financial (AFHP) has bought another IFA. It is paying up to £3.2m for Wirral-based Broadleaf Financial Services.
LF Woodford Equity Income Fund and Woodford Patient Capital Trust own 50.6% of Rutherford Health (RUTH) following the latest cash injection of £12.5m at 176p a share.
StatPro (SOG) is recommending a 230p a share cash bid from Confluence Technologies. That is a 55% premium to the market price and the share price has never been anywhere near that level. It is equivalent to more than 32 times last year’s earnings. Nearly two-thirds of the shares have agreed to accept the offer, which values the asset management software supplier at £161m.
Fulcrum Utility Services (LSE: FCRM) has managed to avoid publicity of its full year figures. On the plus side, they were released before the end of September so there is no danger of trading in the shares being suspended. They were in line with previous indications after multi-utility construction services provider Fulcrum and its auditors finally agreed on the way to interpret IFRS16, which relates to recognising revenues. Fulcrum is no longer allowed to take the revenues and profit from constructing its own utility assets through the income statement. Revenues were one-fifth higher at £48.9m, while underlying pre-tax profit improved from £7.9m to £8.6m. NAV is 20.5p a share.
Background and medical screening checks provider ClearStar (CLSU) grew its interim revenues by 17% to $11.6m and it is getting nearer to profitability. The underlying pre-tax loss was $500,000. This has prompted a small upgrade in the revenues forecast to $23.5m, but additional marketing costs mean that pre-tax loss is still likely to be $600,000. Net debt could be $700,000 at the end of 2019. Demand from the US labour market remains strong and ClearStar is building its presence in newer sectors.
Standard list shell AIQ Ltd (AIQ) is in talks to buy Alchemist Codes, a Malaysian IT consultancy and e-commerce app developer, for £2.3m in shares. Trading in the shares has been suspended. Due diligence is ongoing, and the shares will remain suspended until a readmission document relating to the reverse takeover is published.
Advanced materials supplier Low and Bonar (LWB) is recommending a 15.5p a share cash bid from Germany-based FVB that values the company at £107m. The bidder says that its geographic reach will widen, and it will be able to enter the coated technical textiles market. Recent trading at Low and Bonar has been poor.
National Word (NWOR) is a standard list shell that has been launched by former Mirror boss David Montgomery so that he can acquire UK local newspapers.
Toiletries manufacturer Creightons (CRL) has agreed to acquire its premises in Peterborough for £3.8m. This needs to be agreed to be shareholders at a general meeting.
Argo Blockchain (ARB) has installed a further 1,000 cryptomining machines, taking the total to 6,000. That figure could double by next spring. In the six months to June 2019, Argo generated revenues of £2.93m and made a pre-tax profit of £947,000.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.